Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Innovative Sleep Tech | Inspire Medical Systems leads in Hypoglossal Nerve Stimulation for sleep apnea, with a strong market position and impressive profit margins |
Financial Milestones | Q1 2025 marks sustained profitability and robust revenue growth, with EPS guidance of $2.10-2.20 for 2025 surpassing analyst expectations |
Expanding Horizons | Delve into Inspire's strategic growth through new centers, sales territories, and the game-changing Inspire V platform launch |
Market Valuation | Analysts set price targets ranging from $172 to $270, reflecting confidence in Inspire's potential despite near-term product transition challenges |
Metrics to compare | INSP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINSPPeersSector | |
---|---|---|---|---|
P/E Ratio | 51.4x | −2.6x | −0.6x | |
PEG Ratio | 0.07 | 0.03 | 0.00 | |
Price/Book | 4.0x | 2.8x | 2.6x | |
Price / LTM Sales | 3.2x | 2.5x | 3.3x | |
Upside (Analyst Target) | 62.5% | 52.1% | 38.7% | |
Fair Value Upside | Unlock | 8.8% | 5.1% | Unlock |